D'ANGELO, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 1.054
EU - Europa 678
AS - Asia 392
SA - Sud America 50
AF - Africa 3
OC - Oceania 2
Totale 2.179
Nazione #
US - Stati Uniti d'America 1.035
SG - Singapore 284
IE - Irlanda 230
IT - Italia 216
SE - Svezia 74
CN - Cina 62
BR - Brasile 45
RU - Federazione Russa 41
DE - Germania 29
GB - Regno Unito 14
FR - Francia 13
AT - Austria 11
CA - Canada 10
FI - Finlandia 9
BE - Belgio 8
TR - Turchia 8
JP - Giappone 7
NL - Olanda 7
ES - Italia 5
HK - Hong Kong 5
LT - Lituania 4
PA - Panama 4
PL - Polonia 4
VN - Vietnam 4
AE - Emirati Arabi Uniti 3
CU - Cuba 3
IL - Israele 3
IN - India 3
BG - Bulgaria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
KR - Corea 2
NZ - Nuova Zelanda 2
PE - Perù 2
TW - Taiwan 2
UA - Ucraina 2
AR - Argentina 1
BD - Bangladesh 1
BS - Bahamas 1
CO - Colombia 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
IQ - Iraq 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
MA - Marocco 1
MX - Messico 1
PK - Pakistan 1
PS - Palestinian Territory 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
VE - Venezuela 1
Totale 2.179
Città #
Chandler 292
Dublin 230
Singapore 193
Ashburn 102
Princeton 66
Jacksonville 58
Pescara 43
Altamura 35
Santa Clara 27
Wilmington 26
The Dalles 25
Los Angeles 16
Milan 14
Rome 14
Falls Church 13
New York 13
Washington 13
Chieti 12
Düsseldorf 10
Pavia 10
Brussels 8
Lauterbourg 8
Nuremberg 8
Ann Arbor 7
Ascoli Piceno 7
Kocaeli 7
Boardman 6
Frankfurt am Main 6
Lappeenranta 6
Shenzhen 6
São Paulo 6
Amsterdam 5
Beijing 5
Montreal 5
Tokyo 5
Toronto 5
Vienna 5
Ancona 4
Bologna 4
Dong Ket 4
Hong Kong 4
Nanjing 4
Norwalk 4
Panama City 4
Boston 3
Chengdu 3
Dallas 3
Edinburgh 3
Fortaleza 3
Guangzhou 3
Havana 3
Helsinki 3
London 3
Atlanta 2
Auckland 2
Avezzano 2
Barbarano Vicentino 2
Changsha 2
Chicago 2
Corridonia 2
Dongguan 2
Goyang-si 2
Guglionesi 2
Hangzhou 2
Hyderabad 2
Karasawa 2
Klausen 2
Madrid 2
Moscow 2
Portsmouth 2
Providence 2
Riccia 2
Romola 2
Roseto degli Abruzzi 2
Seattle 2
Sofia 2
Stanford 2
Stockholm 2
Taipei 2
Xi'an 2
Zurich 2
Al Ain City 1
Amaraji 1
Amman 1
Angatuba 1
Araguaína 1
Baghdad 1
Batalha 1
Belém 1
Bend 1
Bhubaneswar 1
Birmingham 1
Bogotá 1
Brasília 1
Brno 1
Brooklyn 1
Buckingham 1
Camapuã 1
Campo Bom 1
Campodipietra 1
Totale 1.447
Nome #
Involvement of DNA Base Excision Repair (BER) in Early Stages of Thyroid Carcinogenesis and Its Correlations with Clinical Features and Inflammatory Microenvironment 81
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations 71
Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study 68
Endometrial stromal sarcomas with sex cord differentiation are associated with phf1 rearrangement 67
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type 64
Endometrioid endometrial carcinomas with microcystic, elongated, and fragmented (MELF) type of myoinvasion: role of immunohistochemistry in the detection of occult lymph node metastases and their clinical significance 63
POLE exonuclease domain mutations in endometrial carcinoma: a case report 62
Placental histopathology after SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis 62
Expression profiling of 22 genes involved in the PI3K-AKT pathway identifies two subgroups of high-grade endometrial carcinomas with different molecular alterations 61
Stromal signatures in endometrioid endometrial carcinomas 61
Placental site trophoblastic tumor (PSTT): a case report and review of the literature 60
A surprising evolution from oral human papillomavirus 16 infection to lymph node metastasis of tonsilar squamous cell carcinoma in an HIV-infected patient 60
Uterine sarcomas: A review 60
Classification of ovarian carcinomas based on pathology and molecular genetics 59
Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system 58
Uterine leiomyosarcomas: Tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis 57
Myometrial invasion and lymph node metastasis in endometrioid carcinomas: Tumor-associated macrophages, microvessel density, and HIF1A have a crucial role 57
The fibroid as clinical problem 57
Atypical Endometrial Hyperplasia, Low-grade: "Much ADO About Nothing" 57
Loss-of-function variants in myocardin cause congenital megabladder in humans and mice 54
Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells 52
The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinoma 52
Diagnostic use of immunohistochemistry in uterine mesenchymal tumors 52
Gene expression analysis identifies two groups of ovarian high-grade serous carcinomas with different prognosis 52
Pathology of mixed Müllerian tumours 51
Molecular analyses of juvenile granulosa cell tumors bearing AKT1 mutations provide insights into tumor biology and therapeutic leads 50
CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas 49
Mixed and ambiguous endometrial carcinomas 47
Simultaneous carcinomas of the breast and ovary: Utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases 45
Mixed endometrial carcinomas with a “low-grade serous”–like component: a clinicopathologic, immunohistochemical, and molecular genetic study 45
Squamous cell carcinoma of the ovary arising from a mucinous cystic tumor of endocervical (Müllerian) type 44
Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary 43
null 43
Undifferentiated and Dedifferentiated Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis 42
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4 38
BRCA gene amplification in primary peritoneal high-grade serous carcinoma patient with intrinsic resistance to platinum treatment: a case report 35
Extracellular vesicles during the three trimesters of pregnancy 29
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 29
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma—A Study by the Spanish Group for Ovarian Cancer Research (GEICO) 28
Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study 27
19. Uterine smooth muscle tumors. 24
Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging 24
12. Cervical glandular neoplasia 24
31. The Peritoneum 24
30. Metastatic tumors of the ovary. 22
Erratum: Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4 (Nature Genetics (2014) 46 (427-429)) 22
Brenner Tumors and Transitional Cell Tumors of the Ovary. 21
Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor 19
Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics 19
Diagnostic challenges in endocervical adenocarcinoma 17
Ovarian Carcinomas: Clinicopathologic and Molecular Features With Comments on 2014 FIGO Staging 16
PI-RADS in Predicting csPCa: A Comparison Between Academic and Nonacademic Centers 16
Ovarian Cancer: Pathology and Genetics 7
Ovarian Mixed Epithelial–Stromal Tumors 6
Non-neoplastic and Tumor-like Conditions of the Ovary. 6
Ovarian carcinomas: clinicopathological and molecular characteristics. Comments on the 2014 FIGO staging system 5
Role of frozen section in Gynecology Oncology 5
Pathological pathway adaptations for adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA).|Adattamenti dei percorsi patologici in funzione del trattamento con osimertinib in adiuvante nei pazienti con NSCLC in stadio precoce (IB-IIIA) 5
Totale 2.374
Categoria #
all - tutte 14.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.742


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202037 0 0 0 0 0 0 0 0 0 0 0 37
2020/2021184 5 20 81 13 8 29 5 1 2 7 6 7
2021/2022183 10 2 0 3 6 13 3 10 18 7 21 90
2022/2023720 86 121 31 78 48 115 44 63 74 5 39 16
2023/2024484 28 17 34 11 27 149 116 31 13 24 7 27
2024/2025766 68 154 93 23 31 53 62 50 121 73 38 0
Totale 2.374